Related Experiment Video
Updated: Jul 13, 2026

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays
Published on: October 23, 2019
Targeting protein multiple conformations: a structure-based strategy for kinase drug design
Jeffrey Jie-Lou Liao1, Robert C Andrews
1TransTech Pharma Inc., 4170 Mendenhall Oaks Pkwy, High Point, NC 27265, USA. jliao@ttpharma.com
Designing small-molecule inhibitors targeting protein kinase multiple conformations offers distinct therapeutic profiles. This approach provides a strategy to overcome drug resistance in kinase therapy.
Area of Science:
- Biochemistry
- Medicinal Chemistry
- Pharmacology
Background:
- Protein kinases are crucial drug targets, but resistance limits efficacy.
- Kinases exist in multiple conformations, influencing inhibitor binding.
- Small-molecule inhibitors targeting specific conformations are emerging.
Purpose of the Study:
- To analyze and classify kinase binding pockets across different conformational states.
- To provide a structure-based rationale for designing inhibitors against multiple kinase conformations.
- To exemplify the strategy of targeting kinase conformations with existing drugs.
Main Methods:
- Structure-based analysis of kinase catalytic clefts.
- Classification of binding pockets in various conformational states.
- Review of clinically relevant small-molecule kinase inhibitors.
Main Results:
- Identified and classified distinct binding pockets in different kinase conformations.
- Demonstrated how targeting these pockets can lead to unique inhibitor profiles.
- Provided examples of successful drugs utilizing this strategy.
Conclusions:
- Targeting multiple protein kinase conformations is a viable strategy for drug design.
- This approach offers a rationale for developing inhibitors that circumvent drug resistance mutations.
- Structure-based analysis is key to advancing antikinase therapy.
Related Concept Videos
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Receptor Tyrosine Kinases
